BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Samsung Biologics Acquires GSK Rockville Facility To Establish First US Manufacturing Site

- Secures the company’s first U.S.-based manufacturing site, strengthening and diversifying its global supply network - Additional investments plann...

December 22, 2025 | News

Ferronova Raises $6 Million To Advance Nanoparticle Guided Cancer Surgery Technology

Australian company Ferronova has raised a further $6 million to progress the commercialisation of a novel nanoparticle image-guided surgery solut...

December 18, 2025 | News

GenSci, RTW And Yarrow Forge US Focused Biotech Partnership To Advance First In Class Thyroid Autoimmune Therapy

Collaboration to focus on building a leading, US-based biotech dedicated to addressing underserved patients impacted by autoimmune and endocrinology di...

December 17, 2025 | News

Zealand Pharma And OTR Therapeutics Forge Strategic Collaboration To Advance Next Generation Metabolic Therapies

Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and...

December 12, 2025 | News

D3 Bio Secures One Hundred 8M$ In Series B Funding To Advance Global Late Stage Oncology Trials

D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology therapeutics, announced the completio...

December 11, 2025 | News

GHIT Fund Invests JPY 70 Million In Prototype Mpox Detection Test Development

The Global Health Innovative Technology (GHIT) Fund announced today an investment of approximately JPY 70 million (USD 460,0001) for the dev...

December 09, 2025 | News

The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech

Global pharmaceutical companies are racing to tap China’s new AI-powered biotech platforms to discover drugs faster and cheaper. In 2025, major Weste...

November 27, 2025 | Analysis

Abbott to Acquire Exact Sciences for $21 Billion to Transform Cancer Diagnostics

Acquisition adds a new growth vertical to Abbott's already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. canc...

November 21, 2025 | News

Lumonus Raises A$25 Million Series B to Accelerate Global Adoption of Its AI-Powered Oncology Workflow Platform

Lumonus, a leader in AI powered radiation oncology workflow solutions, announced the close of its A$25 million Series B financing round. The roun...

November 10, 2025 | News

Ailux and Eli Lilly Forge $345 Million AI-Driven Collaboration to Accelerate Bispecific Antibody Discovery

Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a stra...

November 06, 2025 | News

4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...

November 04, 2025 | News

4D Molecular Therapeutics and Otsuka Form $471 Million Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacific

4DMT to receive $85 million upfront cash payment and expect to receive at least $50 million of cost sharing from Otsuka over the next three years for dev...

November 04, 2025 | News

Peli BioThermal Expands Allentown Service Center to Strengthen Global Pharmaceutical Cold Chain Network

Peli BioThermal, the global leader in temperature-controlled packaging solutions, announced that its newly expanded Allentown, Pennsylvania Service Cente...

November 04, 2025 | News

Samsung Epis Holdings Established as New Biotechnology Investment Holding Company Following Spin-Off from Samsung Biologics

Samsung Epis Holdings Co., Ltd.announced its establishment as a new investment holding company, following the spin-off of Samsung Bioepis Co., Ltd. from Sa...

November 04, 2025 | News

Stay Connected